OBGYN & Reproduction Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN & Reproduction Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Pharmaceutical company divests stake in Medac GmbH, Hamburg
July 4th, 2005
Schering AG, Germany (SHR) announced that it has sold its 25% stake in Medac GmbH, Hamburg, to the shareholders of Medac GmbH for a 2-digit million Euro figure. At the same time, Schering has acquired from Medac the remaining 50% of the shares in Medac Schering Onkologie GmbH. The activities of this company are to be integrated into a new oncology business unit at Schering Deutschland GmbH, Schering's German subsidiary. The employees of Medac Schering Onkologie GmbH will be taken over by Schering Deutschland GmbH. Medac Schering Onkologie GmbH was founded in 2000 as a joint venture between Schering and Medac and focuses on the marketing of products...
Source: OBGYN & Reproduction Week (2005-07-04)
|
